The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.
Open accessAbstract
Corticosteroid-induced osteoporosis is the most common secondary cause of osteoporosis. We conducted a 12-mo, randomized clinical trial of human parathyroid hormone 1-34 (hPTH 1-34) in postmenopausal women (mean age was 63 yr) with osteoporosis who were taking corticosteroids and hormone replacement therapy. Response to the treatment was assessed with bone mineral density (BMD) measurements of the lumbar spine by quantitative computed tomography (QCT); BMD measurements of the lumbar spine, hip, and forearm by dual-energy x-ray absorptiometry (DXA); and biochemical markers of bone turnover. The mean (+/-SE) changes in BMD of the lumbar spine by QCT and DXA in the PTH group were 35+/-5.5% and 11+/-1.4%, respectively, compared with a relatively small change of 1.7+/-1.8% and 0+/-0.9% in the estrogen-only group. The differences in mean percentage between the groups at 1 yr were 33.5% for the lumbar spine by QCT (P < 0.001) and 9.8% for the lumbar spine by DXA (P < 0.001). The changes in the hip and forearm were not significantly different between or within the groups. During the first 3 mo of PTH treatment, markers of bone formation increased to nearly 150%, whereas markers of bone resorption increased only 100%, suggesting an early uncoupling of bone turnover in favor of formation. These results suggest that parathyroid hormone dramatically increases bone mass in the central skeleton of postmenopausal women with corticosteroid- induced osteoporosis who are taking hormone replacement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Self-citationBone density at various sites for prediction of hip fractures
Cummings, S. R., Browner, W., Cummings, S. R., Black, D. M., Nevitt, M. C., Browner, W., Genant, H. K., Cauley, J., Ensrud, K., Scott, J., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92555-8 · Cited by 2,446
Self-citationAlendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Self-citationEffect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with Osteoporosis
Riggs, B. L., Hodgson, S. F., O'Fallon, W. M., Chao, E. Y. S., Wahner, H. W., Muhs, J. M., Cedel, S. L., & Melon, L. J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003223221203 · Cited by 1,088
Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management
Lukert, B. P., & Raisz, L. G. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-352 · Cited by 1,066
Lindsay, R., Nieves, J., Formica, C., Henneman, E., Woelfert, L., Shen, V., Dempster, D., & Cosman, F. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02342-8 · Cited by 749
Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis
Adachi, J. D., Bensen, W. G., Brown, J., Hanley, D., Hodsman, A., Josse, R., Kendler, D. L., Lentle, B., Olszynski, W., Ste.-Marie, L.-G., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370603 · Cited by 685
TAM, C. S., HEERSCHE, J. N. M., MURRAY, T. M., & PARSONS, J. A. (1982) · Endocrinology · doi:10.1210/endo-110-2-506 · Cited by 612
Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin
Sambrook, P., Birmingham, J., Kelly, P., Kempler, S., Nguyen, T., Pocock, N., & Eisman, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282404 · Cited by 520
Dr. Slovik, D. M., Rosenthal, D. I., Doppelt, S. H., Potts, J. T., Daly, M. A., Campbell, J. A., & Neer, R. M. (1986) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650010411 · Cited by 348
Black, D. M., Palermo, L., Nevitt, M. C., Genant, H. K., Epstein, R., Valentin, R. S., & Cummings, S. R. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100610 · Cited by 253
Self-citationDempster, D. W., Arlot, M. A., & Meunier, P. J. (1983) · Calcified Tissue International · doi:10.1007/bf02405069 · Cited by 233
Hall, G. M., Daniels, M., Doyle, D. V., & Spector, T. D. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371014 · Cited by 229
Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss
Lukert, B. P., Johnson, B. E., & Robinson, R. G. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070909 · Cited by 212
Lee, K., Deeds, J. D., Chiba, S., UN-NO, M., Bond, A., & Segre, G. V. (1994) · Endocrinology · doi:10.1210/endo.134.1.8275957 · Cited by 207
Lee, K. (1994) · Endocrinology · doi:10.1210/en.134.1.441 · Cited by 181
Quantitative computed tomography in assessment of osteoporosis
Genant, H. K., Block, J. E., Steiger, P., Glueer, C.-C., & Smith, R. (1987) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(87)80024-7 · Cited by 167
Self-citationMosekilde, L., Danielsen, C. C., & Gasser, J. A. (1994) · Endocrinology · doi:10.1210/endo.134.5.8156913 · Cited by 154
Corticosteroid-induced osteoporosis
Adachi, J. D., Bensen, W., & Hodsman, A. B. (1993) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(05)80029-0 · Cited by 151
An evaluation of antibodies and clinical resistance to salmon calcitonin
Singer, F. R., Aldred, J. P., Neer, R. M., Krane, S. M., Potts, J. T. J., & Bloch, K. J. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107044 · Cited by 137
REEVE, J., Bradbeer, J. N., ARLOT, M. E., Davies, U. M., Green, J. R., Hampton, L., Edouard, C. M., Hesp, R., Hulme, P., Ashby, J. P., et al. (1991) · Osteoporosis International · doi:10.1007/bf01625448 · Cited by 125
Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats
Meng, X., Liang, X. G., Birchman, R., Wu, D. D., Dempster, D. W., Lindsay, R., & Shen, V. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110402 · Cited by 99
Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol
Neer, M., Slovik, D. M., Daly, M., POTTS, T. M., & Nussbaum, S. R. (1993) · Osteoporosis International · doi:10.1007/bf01621907 · Cited by 94
Animal models of cortical porosity
Sietsema, W. K. (1995) · Bone · doi:10.1016/8756-3282(95)00307-y · Cited by 68
Brockstedt, H. K., Christiansen, P., Mosekilde, L., & Melsen, F. (1995) · Bone · doi:10.1016/8756-3282(95)80020-q · Cited by 44
Corticosteroid-induced osteoporosis
Joseph, J. C. (1994) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/51.2.188 · Cited by 43
Cited by
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
Papaioannou, A., Morin, S., Cheung, A. M., Atkinson, S., Brown, J. P., Feldman, S., Hanley, D. A., Hodsman, A., Jamal, S. A., Kaiser, S. M., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.100771 · Cited by 1,749
Black, D. M., Greenspan, S. L., Ensrud, K. E., Palermo, L., McGowan, J. A., Lang, T. F., Garnero, P., Bouxsein, M. L., Bilezikian, J. P., & Rosen, C. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa031975 · Cited by 1,174
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
Metadata
- Authors
- Lane, N. E., Sanchez, S., Modin, G. W., Genant, H. K., Pierini, E., & Arnaud, C. D.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-10-15
- Volume
- 102
- Issue
- 8
- Pages
- 1627-1633
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2127733654
- Cited by
- 529
- References
- 26
- FWCI
- 26.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.